UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 53

Sortiert nach

Abstract 1092: Alterations of the retinoblastoma gene in stage III breast cancers

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.1092-1092

2010

Volltextzugriff (PDF)

Abstract 1792: MDM2 promoter variants and mRNA expression in irradiated lymphocytes

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.1792-1792

2013

Volltextzugriff (PDF)

Abstract 3704: Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertension in a single-arm Phase II study

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.3704-3704

2012

Volltextzugriff (PDF)

Abstract CT010: Efficacy results based on PIK3CA status in BELLE-3: A Phase 3 study of buparlisib (BKM120) + fulvestrant in postmenopausal women with aromatase inhibitor-treated, HR+/HER2- ABC after progression on an mTOR inhibitor

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.CT010-CT010

2017

Volltextzugriff (PDF)

Adjuvant Aromatase Inhibitors for Early Breast Cancer After Chemotherapy-Induced Amenorrhoea: Caution and Suggested Guidelines

Journal of clinical oncology, 2006-06, Vol.24 (16), p.2444-2447

2006

Volltextzugriff (PDF)

Antitumor efficacy improved by local delivery of species-specific endostatin

Journal of neurosurgery, 2006, Vol.104 (1), p.118-128

2006

Volltextzugriff (PDF)

Aromatase Inhibition: Translation into a Successful Therapeutic Approach

Clinical cancer research, 2005-04, Vol.11 (8), p.2809-2821

2005

Volltextzugriff (PDF)

Aromatase inhibitors and inactivators for breast cancer therapy

Drugs & aging, 2002, Vol.19 (4), p.277-298

LØNNING, Per E

2002

Volltextzugriff (PDF)

Changes in folate status as determined by reduction in total plasma homocysteine levels during leucovorin modulation of 5-fluorouracil therapy in cancer patients

Clinical cancer research, 1998-09, Vol.4 (9), p.2125-2128

1998

Volltextzugriff (PDF)

Decreased serum concentrations of tamoxifen and its metabolites induced by aminoglutethimide

Cancer research (Chicago, Ill.), 1990-09, Vol.50 (18), p.5851

1990

Volltextzugriff (PDF)

Disease-Related Outcomes With Long-Term Follow-Up: An Updated Analysis of the Intergroup Exemestane Study

Journal of clinical oncology, 2012-03, Vol.30 (7), p.709-717

2012

Volltextzugriff (PDF)

Does adjuvant therapy with letrozole improve survival in postmenopausal women with early-stage breast cancer?

Nature clinical practice. Oncology, 2006-07, Vol.3 (7), p.356-357

2006

Volltextzugriff (PDF)

Effect of aminoglutethimide on antipyrine, theophylline, and digitoxin disposition in breast cancer

Clinical pharmacology and therapeutics, 1984-12, Vol.36 (6), p.796-802

1984

Volltextzugriff (PDF)

Effects of Exemestane Administered for 2 Years Versus Placebo on Bone Mineral Density, Bone Biomarkers, and Plasma Lipids in Patients With Surgically Resected Early Breast Cancer

Journal of clinical oncology, 2005-08, Vol.23 (22), p.5126-5137

2005

Volltextzugriff (PDF)

Elevated levels of the steroidogenic factor 1 are associated with over-expression of CYP19 in an oestrogen-producing testicular Leydig cell tumour

European journal of endocrinology, 2012-05, Vol.166 (5), p.941

2012

Volltextzugriff (PDF)

Endocrine effects of aromatase inhibitors

Journal of clinical oncology, 2010-02, Vol.28 (6), p.e101-e102

2010

Volltextzugriff (PDF)

Endocrine effects of nonsteroidal aromatase inhibitors and their clinical impact

Journal of clinical oncology, 2002-07, Vol.20 (13), p.3039-3040

2002

Volltextzugriff (PDF)

Endocrine therapy and bone loss in breast cancer: time to close in the RANK(L)?

Journal of clinical oncology, 2008-10, Vol.26 (30), p.4859-4861

Lønning, Per E

2008

Volltextzugriff (PDF)

Exemestane for Breast Cancer Prevention: A Feasible Strategy?

Clinical cancer research, 2005-01, Vol.11 (2), p.918s-924s

Per E. Lønning

2005

Volltextzugriff (PDF)

Gene Expression Patterns of Breast Carcinomas Distinguish Tumor Subclasses with Clinical Implications

Proceedings of the National Academy of Sciences - PNAS, 2001-09, Vol.98 (19), p.10869-10874

2001

Volltextzugriff (PDF)

Gene Expression Profiling of Breast Cancer in Relation to Estrogen Receptor Status and Estrogen-Metabolizing Enzymes: Clinical Implications

Clinical cancer research, 2005-01, Vol.11 (2), p.878s-883s

2005

Volltextzugriff (PDF)

Genetic and Epigenetic Changes in p21 and p21B Do Not Correlate with Resistance to Doxorubicin or Mitomycin and 5-Fluorouracil in Locally Advanced Breast Cancer

Clinical cancer research, 2004-05, Vol.10 (10), p.3438-3443

2004

Volltextzugriff (PDF)

Genome sequencing for personalized cancer treatment

Tidsskrift for den Norske Lægeforening, 2012-11, Vol.132 (21), p.2406-2408

2012

Volltextzugriff (PDF)

Genomsekvensering for persontilpasset kreftbehandling

Tidsskrift for den Norske Lægeforening, 2012, Vol.132 (21), p.2406-2408

2012

Volltextzugriff (PDF)

Golgi-localized PAQR4 mediates Anti-apoptotic Ceramidase Activity in Breast Cancer

Cancer research (Chicago, Ill.), 2020-04

2020

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

KollektionPublisher or Other Site

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(53)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Abstract 1092: Alterations of the retinoblastoma gene in stage III breast cancers

Abstract 1792: MDM2 promoter variants and mRNA expression in irradiated lymphocytes

Abstract 3704: Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertension in a single-arm Phase II study

Abstract CT010: Efficacy results based on PIK3CA status in BELLE-3: A Phase 3 study of buparlisib (BKM120) + fulvestrant in postmenopausal women with aromatase inhibitor-treated, HR+/HER2- ABC after progression on an mTOR inhibitor

Adjuvant Aromatase Inhibitors for Early Breast Cancer After Chemotherapy-Induced Amenorrhoea: Caution and Suggested Guidelines

Antitumor efficacy improved by local delivery of species-specific endostatin

Aromatase Inhibition: Translation into a Successful Therapeutic Approach

Aromatase inhibitors and inactivators for breast cancer therapy

Changes in folate status as determined by reduction in total plasma homocysteine levels during leucovorin modulation of 5-fluorouracil therapy in cancer patients

Decreased serum concentrations of tamoxifen and its metabolites induced by aminoglutethimide

Disease-Related Outcomes With Long-Term Follow-Up: An Updated Analysis of the Intergroup Exemestane Study

Does adjuvant therapy with letrozole improve survival in postmenopausal women with early-stage breast cancer?

Effect of aminoglutethimide on antipyrine, theophylline, and digitoxin disposition in breast cancer

Effects of Exemestane Administered for 2 Years Versus Placebo on Bone Mineral Density, Bone Biomarkers, and Plasma Lipids in Patients With Surgically Resected Early Breast Cancer

Elevated levels of the steroidogenic factor 1 are associated with over-expression of CYP19 in an oestrogen-producing testicular Leydig cell tumour

Endocrine effects of aromatase inhibitors

Endocrine effects of nonsteroidal aromatase inhibitors and their clinical impact

Endocrine therapy and bone loss in breast cancer: time to close in the RANK(L)?

Exemestane for Breast Cancer Prevention: A Feasible Strategy?

Gene Expression Patterns of Breast Carcinomas Distinguish Tumor Subclasses with Clinical Implications

Gene Expression Profiling of Breast Cancer in Relation to Estrogen Receptor Status and Estrogen-Metabolizing Enzymes: Clinical Implications

Genetic and Epigenetic Changes in p21 and p21B Do Not Correlate with Resistance to Doxorubicin or Mitomycin and 5-Fluorouracil in Locally Advanced Breast Cancer

Genome sequencing for personalized cancer treatment

Genomsekvensering for persontilpasset kreftbehandling

Golgi-localized PAQR4 mediates Anti-apoptotic Ceramidase Activity in Breast Cancer

Aktive Filter

Suchergebnisse filtern